105 related articles for article (PubMed ID: 25597344)
1. Alkaline phosphatase: better than PTH as a marker of cardiovascular and bone disease?
Lau WL; Kalantar-Zadeh K; Kovesdy CP; Mehrotra R
Hemodial Int; 2014 Oct; 18(4):720-4. PubMed ID: 25597344
[No Abstract] [Full Text] [Related]
2. Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.
Haarhaus M; Monier-Faugere MC; Magnusson P; Malluche HH
Am J Kidney Dis; 2015 Jul; 66(1):99-105. PubMed ID: 25843703
[TBL] [Abstract][Full Text] [Related]
3. Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients.
Couttenye MM; D'Haese PC; Van Hoof VO; Lemoniatou E; Goodman W; Verpooten GA; De Broe ME
Nephrol Dial Transplant; 1996 Jun; 11(6):1065-72. PubMed ID: 8671970
[TBL] [Abstract][Full Text] [Related]
4. [Bone biomarkers in haemodialysis patients: bone alkaline phosphatase or ß-Crosslaps?].
Jean G; Souberbielle JC; Granjon S; Lorriaux C; Hurot JM; Mayor B; Deleaval P; Chazot C
Nephrol Ther; 2013 Jun; 9(3):154-9. PubMed ID: 23545236
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.
Sprague SM; Bellorin-Font E; Jorgetti V; Carvalho AB; Malluche HH; Ferreira A; D'Haese PC; Drüeke TB; Du H; Manley T; Rojas E; Moe SM
Am J Kidney Dis; 2016 Apr; 67(4):559-66. PubMed ID: 26321176
[TBL] [Abstract][Full Text] [Related]
6. Calcitropic hormonal status in north Indian patients with end-stage renal disease.
Singh AK; Avula S; Kher V; Rao DS; Mithal A
Natl Med J India; 1999; 12(5):202-7. PubMed ID: 10612998
[TBL] [Abstract][Full Text] [Related]
7. [Is it possible to-predict fracture in CKD patients?].
Tsukamoto Y
Clin Calcium; 2016 Sep; 26(9):1295-300. PubMed ID: 27561344
[TBL] [Abstract][Full Text] [Related]
8. Does PTH offer additive value to ALP measurement in assessing CKD-MBD?
Lamb EJ; Delaney MP
Perit Dial Int; 2014; 34(7):687-91. PubMed ID: 25520480
[No Abstract] [Full Text] [Related]
9. News on biomarkers in CKD-MBD.
Mazzaferro S; Tartaglione L; Rotondi S; Bover J; Goldsmith D; Pasquali M
Semin Nephrol; 2014 Nov; 34(6):598-611. PubMed ID: 25498379
[TBL] [Abstract][Full Text] [Related]
10. PTH and bone markers of renal osteodystrophy in predialysis chronic renal failure.
Coen G; Mazzaferro S; Ballanti P; Bonucci E
J Endocrinol Invest; 1992; 15(9 Suppl 6):129-33. PubMed ID: 1300330
[No Abstract] [Full Text] [Related]
11. Parathormone and bone-specific alkaline phosphatase for the follow-up of bone turnover in hemodialysis patients: is it so simple?
Delanaye P; Dubois BE; Jouret F; Krzesinski JM; Moranne O; Cavalier E
Clin Chim Acta; 2013 Feb; 417():35-8. PubMed ID: 23262367
[TBL] [Abstract][Full Text] [Related]
12. The relationship between total mass and blood supply of parathyroid glands and their secretion of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism.
Ahmadi F; Aghajanzadeh P; Yazdi HR; Maziar S; Gatmiri SM
Saudi J Kidney Dis Transpl; 2016 Mar; 27(2):263-9. PubMed ID: 26997379
[TBL] [Abstract][Full Text] [Related]
13. A new approach for evaluating bone turnover in chronic kidney disease.
Tolouian R; Hernandez GT; Chiang WY; Gupta A
Eur J Intern Med; 2010 Jun; 21(3):230-2. PubMed ID: 20493428
[TBL] [Abstract][Full Text] [Related]
14. Immunoradiometric assay for intact human parathyroid hormone: characteristics, clinical application and comparison with a radio-immunoassay.
Frölich M; Walma ST; Paulson C; Papapoulos SE
Ann Clin Biochem; 1990 Jan; 27 ( Pt 1)():69-72. PubMed ID: 2310159
[TBL] [Abstract][Full Text] [Related]
15. The possible role of calcitonin deficiency in the development of bone disease due to chronic renal failure.
Kanis JA; Earnshaw M; Heynen G; Russell RG; Woods CG
Calcif Tissue Res; 1977 May; 22 Suppl():147-53. PubMed ID: 912516
[No Abstract] [Full Text] [Related]
16. Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction.
Yamada S; Inaba M; Kurajoh M; Shidara K; Imanishi Y; Ishimura E; Nishizawa Y
Clin Endocrinol (Oxf); 2008 Aug; 69(2):189-96. PubMed ID: 18221403
[TBL] [Abstract][Full Text] [Related]
17. Bone alkaline phosphatase in CKD-mineral bone disorder.
Sardiwal S; Magnusson P; Goldsmith DJ; Lamb EJ
Am J Kidney Dis; 2013 Oct; 62(4):810-22. PubMed ID: 23623575
[TBL] [Abstract][Full Text] [Related]
18. Correlation of serum alkaline phosphatase with bone formation rates.
Shifrin LZ
Clin Orthop Relat Res; 1970; 70():212-5. PubMed ID: 5445727
[No Abstract] [Full Text] [Related]
19. Parathyroid hormone changes during phosphorus load in patients with chronic renal insufficiency with low serum parathyroid hormone or adynamic bone disease.
Cuppari L; Carvalho AB; Lobão RR; Martini LA; Cendoroglo M; Ventura RT; Draibe SA
Clin Nephrol; 2001 Jul; 56(1):35-43. PubMed ID: 11499657
[TBL] [Abstract][Full Text] [Related]
20. [Renal osteodystrophy (I)].
Covic A; Florea L; Ungureanu C; Covic M
Rev Med Chir Soc Med Nat Iasi; 2000; 104(3):31-5. PubMed ID: 12089922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
